Acute Liver Failure

Etiology

Acute Viral Hepatitis

Budd-Chiari Syndrome

Defined as outflow obstruction to the hepatic veins. Typically related to thrombosis, but can be secondary to tumour invasion or vascular membrane destruction. Affects young adults and women more than older people and men. 5-year survival is 50-80%. Generally requires transplantation to avoid mortality. The vast majority of patients have a thrombophilia (malignancy, MPN, protein C or S deficiency, PCV, lupus anticoagulant, ATIII deficiency, APS, etc.).

Although BCS can present acutely (<8 weeks), it is more common to present over 3-4 months with ascites, abdo pain, hepatomegaly, jaundice, coagulopathy, elevations in AST and AP levels. Portal hypertension can be variable.

Diagnosis is clinical and combined with Doppler ultrasonography of the hepatic veins, and may include liver biopsy (transjugular route most common due to coagulopathy).

Management of BCS

Medical management: anticoagulations and diuretics to control ascites. Consider thrombolysis with recent onset of disease.

Interventional therapies: consider portosytemic shunting procedures to prevent progression (TIPSS).

Ultimately, liver transplantation remains the definitive treatment for patients failing medical and shunting interventions. They usually require anticoagulation in the immediate postoperative period.